Lukas Klein

1.1k total citations
12 papers, 596 citations indexed

About

Lukas Klein is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Lukas Klein has authored 12 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Lukas Klein's work include Pancreatic and Hepatic Oncology Research (5 papers), HIV Research and Treatment (2 papers) and Phagocytosis and Immune Regulation (2 papers). Lukas Klein is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), HIV Research and Treatment (2 papers) and Phagocytosis and Immune Regulation (2 papers). Lukas Klein collaborates with scholars based in Germany, United States and United Kingdom. Lukas Klein's co-authors include Shiv K. Singh, Uday Kishore, Abhishek Shastri, Hadida Yasmin, Anthony G. Tsolaki, Elisa Espinet, Volker Ellenrieder, Ellen Puré, Albrecht Neeße and Caroline S. Verbeke and has published in prestigious journals such as Gut, Science Advances and Frontiers in Immunology.

In The Last Decade

Lukas Klein

9 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Klein Germany 8 243 226 170 110 104 12 596
Viveka Nand Yadav United States 13 127 0.5× 187 0.8× 216 1.3× 178 1.6× 107 1.0× 27 538
Jan Martínek United States 7 397 1.6× 244 1.1× 492 2.9× 57 0.5× 75 0.7× 14 924
Catalina Martínez Colombia 8 397 1.6× 146 0.6× 285 1.7× 63 0.6× 54 0.5× 17 692
Sebastian Newrzela Germany 16 481 2.0× 358 1.6× 258 1.5× 75 0.7× 37 0.4× 29 844
Boris Brill Germany 15 183 0.8× 266 1.2× 177 1.0× 62 0.6× 61 0.6× 33 578
Carl‐Magnus Högerkorp Sweden 11 105 0.4× 264 1.2× 309 1.8× 59 0.5× 33 0.3× 16 662
Tiangui Huang United States 12 225 0.9× 324 1.4× 133 0.8× 83 0.8× 112 1.1× 19 790
Jessica Fioravanti Spain 15 400 1.6× 209 0.9× 559 3.3× 28 0.3× 76 0.7× 22 998
Amotz Ziv-Av United States 10 98 0.4× 439 1.9× 59 0.3× 110 1.0× 204 2.0× 10 696
Anna Merlo Italy 17 384 1.6× 332 1.5× 254 1.5× 25 0.2× 115 1.1× 32 825

Countries citing papers authored by Lukas Klein

Since Specialization
Citations

This map shows the geographic impact of Lukas Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Klein more than expected).

Fields of papers citing papers by Lukas Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Klein. The network helps show where Lukas Klein may publish in the future.

Co-authorship network of co-authors of Lukas Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Klein. A scholar is included among the top collaborators of Lukas Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Klein. Lukas Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Küffer, Stefan, Lukas Klein, Christof Lenz, et al.. (2025). TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. Science Advances. 11(27). eadu2339–eadu2339.
4.
Espinet, Elisa, Lukas Klein, Ellen Puré, & Shiv K. Singh. (2022). Mechanisms of PDAC subtype heterogeneity and therapy response. Trends in cancer. 8(12). 1060–1071. 37 indexed citations
5.
Klein, Lukas, Florian Wegwitz, Elisa Espinet, et al.. (2022). Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. JCI Insight. 7(16). 5 indexed citations
6.
Müller, Dirk, et al.. (2021). Process intensification in the biopharma industry: Improving efficiency of protein manufacturing processes from development to production scale using synergistic approaches. Chemical Engineering and Processing - Process Intensification. 171. 108727–108727. 48 indexed citations
7.
Shastri, Abhishek, Anthony G. Tsolaki, Hadida Yasmin, et al.. (2020). Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. Frontiers in Immunology. 11. 1402–1402. 226 indexed citations
8.
Langer, Simon, Christian Hammer, Lukas Klein, et al.. (2019). HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses. eLife. 8. 53 indexed citations
9.
Bohnenberger, Hanibal, Julia Beck, Kirsten Bornemann-Kolatzki, et al.. (2019). Molecular Classification of Neuroendocrine Tumors of the Thymus. Journal of Thoracic Oncology. 14(8). 1472–1483. 42 indexed citations
10.
Klein, Lukas, et al.. (2019). Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer. Cells. 9(1). 58–58. 10 indexed citations
11.
Yamada, Eri, Shinji Nakaoka, Lukas Klein, et al.. (2018). Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo. Cell Host & Microbe. 23(1). 110–120.e7. 27 indexed citations
12.
Heßmann, Elisabeth, Lukas Klein, Vijayalakshmi Kari, et al.. (2017). Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer. Gut. 67(3). 497–507. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026